Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography.

[1]  M. Schwenk,et al.  Stereoselective glucuronidation of naproxen in isolated cells from liver, stomach, intestine, and colon of the guinea pig. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[2]  K. Bock,et al.  Stereoselective (S)- and (R)-naproxen glucuronosyl transferases of rat liver. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[3]  F. Russel,et al.  Naproxen and indomethacin: disposition and effects in the isolated perfused rat kidney. , 1990, Toxicology letters.

[4]  P. A. Todd,et al.  Naproxen , 1990, Drugs.

[5]  S. Kushinsky,et al.  Isolation and identification of 6-desmethylnaproxen sulfate as a new metabolite of naproxen in human plasma. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[6]  C. Fenselau,et al.  Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[7]  G. Mckay,et al.  Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[8]  L. Benet,et al.  Effect of probenecid on the formation and elimination of acyl glucuronides: Studies with zomepirac , 1985, Clinical pharmacology and therapeutics.

[9]  E M Faed,et al.  Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. , 1984, Drug metabolism reviews.

[10]  R. Day,et al.  Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis , 1982, Clinical pharmacology and therapeutics.

[11]  S. K. Khalil,et al.  An isocratic high-pressure liquid chromatographic determination of naproxen and desmethylnaproxen in human plasma. , 1982, Journal of pharmaceutical sciences.

[12]  S. S. Weber,et al.  Effect of Mylanta on Naproxen Bioavailability , 1981, Therapeutic drug monitoring.

[13]  N. Holford,et al.  Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urine. , 1980, Journal of pharmaceutical sciences.

[14]  S. Bloomfield,et al.  Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. , 1980, British journal of clinical pharmacology.

[15]  R. Williams,et al.  Convenient and sensitive high-performance liquid chromatography assay for ketoprofen, naproxen and other allied drugs in plasma or urine. , 1980, Journal of chromatography.

[16]  E. Mroszczak,et al.  Naproxen‐probenecid interaction , 1978, Clinical pharmacology and therapeutics.

[17]  Y. Miura,et al.  Studies on the fate of naproxen. II. Metabolic fate in various animals and man. , 1978, Chemical & pharmaceutical bulletin.

[18]  M. Anttila.  Fluorometric determination of naproxen in serum. , 1977, Journal of pharmaceutical sciences.

[19]  H. Sevelius,et al.  Pharmacokinetics of naproxen overdoses , 1976, Clinical pharmacology and therapeutics.

[20]  H. Sevelius,et al.  Nonlinear plasma level response to high doses of naproxen , 1974, Clinical pharmacology and therapeutics.

[21]  H. Sevelius,et al.  Naproxen oral absorption characteristics. , 1972, Chemical & pharmaceutical bulletin.

[22]  M. Chaplin,et al.  Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. , 1972, Journal of pharmaceutical sciences.

[23]  G. Levy,et al.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man , 1972, Clinical pharmacology and therapeutics.